|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Angel Yeast expands into probiotics R&D and production
|
|
Friday, 30 August, 2024, 08 : 00 AM [IST]
|
|
Xizang, China
|
Angel Yeast, a global leader in yeast manufacturing, has officially put its plateau probiotics project into production in Xizang, a milestone of the company's biotech transformation strategy and a key step to achieve local, industrialised production of probiotics.
The probiotics product can be applied in the food, healthcare, agriculture industries and more, boasting huge economic value and market potential. Its probiotics production now focuses on three main industrialised strains – the Lactobacillus plantarum S2 has strong acid-producing capacity and excellent fermentation results, which can be utilised in food and agriculture productions; the DB-8 that's mainly applied in dairy products and can make the yogurt to have a natural tomato flavour without additives, which is of high commercial value; and Streptococcus thermophilus, which can prevent the yogurt from further acidification over time to maintain the good taste.
He Xinzhang, general manager of Angel Yeast's subsidiary in Xizang, noted that for three years, the R&D team overcame altitude sickness and visited the herdsmen's families, collected dairy products, and traveled to the high-altitude areas to chase yaks and pick up cow dung, completing a series of microbial resources census collection and evaluation works with fruitful results.
Xinzhang said, "We collected and preserved over 1,800 bacterial strains and identified the ones to be industrialised. Now we not only have the patent-licensed probiotic strains, but also own the independent intellectual property rights of the production process, which together build up our competitive advantages in the market. And as we expand the probiotics project in Xizang we're also building a local talent pipeline of management, finance, and equipment professionals."
|
|
|
|
|
|
|
|
|
|